Bain Capital Life Sciences Investors as of Dec. 31, 2021
Portfolio Holdings for Bain Capital Life Sciences Investors
Bain Capital Life Sciences Investors holds 34 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Springworks Therapeutics (SWTX) | 23.7 | $299M | 4.8M | 61.98 | |
| Dynavax Technologies Corp Com New (DVAX) | 9.4 | $118M | 8.4M | 14.07 | |
| Rapid Micro Biosystems Class A Com (RPID) | 7.1 | $90M | 8.4M | 10.64 | |
| Arcutis Biotherapeutics (ARQT) | 6.5 | $83M | 4.0M | 20.74 | |
| Eqrx | 5.4 | $68M | 10M | 6.82 | |
| Nuvalent Inc-a (NUVL) | 5.2 | $65M | 3.4M | 19.04 | |
| Crinetics Pharmaceuticals In (CRNX) | 4.6 | $58M | 2.0M | 28.41 | |
| C4 Therapeutics Com Stk (CCCC) | 4.2 | $53M | 1.6M | 32.20 | |
| Pharvaris N V (PHVS) | 3.6 | $46M | 3.2M | 14.39 | |
| Xilio Therapeutics (XLO) | 3.6 | $45M | 2.8M | 16.00 | |
| Annexon (ANNX) | 3.0 | $37M | 3.2M | 11.49 | |
| Nurix Therapeutics (NRIX) | 2.9 | $37M | 1.3M | 28.95 | |
| Mersana Therapeutics (MRSN) | 2.7 | $34M | 5.4M | 6.22 | |
| Aptinyx | 1.9 | $24M | 8.9M | 2.67 | |
| Atea Pharmaceuticals (AVIR) | 1.8 | $22M | 2.5M | 8.94 | |
| Tango Therapeutics (TNGX) | 1.7 | $21M | 1.9M | 10.94 | |
| Syros Pharmaceuticals | 1.6 | $20M | 6.3M | 3.26 | |
| Marinus Pharmaceuticals Com New (MRNS) | 1.3 | $17M | 1.4M | 11.88 | |
| Savara (SVRA) | 1.1 | $14M | 12M | 1.24 | |
| Adagio Therapeutics (IVVD) | 1.1 | $14M | 1.9M | 7.26 | |
| Solid Biosciences | 1.1 | $14M | 7.9M | 1.75 | |
| Aeglea Biotherapeutics | 1.1 | $14M | 2.8M | 4.75 | |
| Nautilus Biotechnology (NAUT) | 0.8 | $10M | 2.0M | 5.18 | |
| Research Alliance Corp Ii Com Cl A | 0.8 | $9.8M | 1.0M | 9.77 | |
| Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.6 | $6.9M | 700k | 9.92 | |
| X4 Pharmaceuticals (XFOR) | 0.5 | $6.6M | 2.9M | 2.29 | |
| Bluebird Bio (BLUE) | 0.4 | $5.4M | 538k | 9.99 | |
| Panacea Acquisition Corp Ii Cl A Shs | 0.4 | $4.9M | 500k | 9.70 | |
| Arya Sciences Acquisitn Corp Class A Ord Shs | 0.4 | $4.9M | 500k | 9.70 | |
| Bcls Acquisition Corp Com Cl A | 0.4 | $4.8M | 488k | 9.80 | |
| 2seventy Bio Common Stock (TSVT) | 0.4 | $4.6M | 179k | 25.63 | |
| Omega Alpha Spac Cl A | 0.3 | $3.9M | 400k | 9.77 | |
| Frazier Lifesciences Acqu Unit 12/09/2025 | 0.2 | $3.0M | 300k | 9.92 | |
| Jiya Acquisition Corp Com Cl A | 0.2 | $2.9M | 300k | 9.77 |
